Comparative clinical study of Chandraprabha Udvartana lepa and Raktashodhaka Arka for the management of Mukhadushika w.s.r. to Acne

Effect of Chandraprabha Udvartana lepa and Raktashodhaka Arka in the management of Mukhadushika w.s.r to Acne

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/06/005938

Enrollment

Registered

2015-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from Acne

Interventions

Intervention1: Chandraprabha Udvartana Lepa along with Raktashodhaka Arka: Chandraprabha Udvartana Lepa contains Masoora Chiraungi Pitta sarsapa which will be given for local application dose 15gm per

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from classical signs and symptoms of Mukhadushika will be selected from OPD and IPD of IPGT and RA hospital Jamnagar

Exclusion criteria

Exclusion criteria: Patients having age below 16 years and above 30 years will not be selected for present study. Patients having history of exposure to Bromide and Halogen will be excluded from present study. Carcinogenic condition of sebaceous gland will be excluded from present study. The patient having history of any systemic disease or any viral infection will be excluded from the present study.

Design outcomes

Primary

Measure	Time frame
Relief in signs and symptoms of acneTimepoint: 8 weeks	—

Secondary

Measure	Time frame
enhancement in skin glowTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactShaikh imtiyaz

Institute for Post Graduate Teaching and research in Ayurved

alankruta@yahoo.com9824171817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026